Does aplt likely to go up on 09/20/2024

**Applied Therapeutics (APLT) is likely to experience an upward movement on September 20, 2024**, based on the following analysis: 1. **Recent Positive Developments**: APLT has recently announced a positive FDA update for its lead drug candidate, govorestat, which is being developed to treat Classic Galactosemia. The FDA has waived the advisory committee meeting, signaling confidence in the drug’s safety and efficacy profile. This development is a significant positive catalyst for the company. 2. **Stock Price Momentum**: APLT's stock price has shown a strong upward momentum, increasing by 70.58% from September 17 to September 19, 2024. This momentum is likely to continue on September 20, 2024. 3. **Analyst Ratings and Price Targets**: Despite the lack of profitability expectations, as indicated by the consensus EPS estimate of -$0.16, the average price target of $6.67 suggests that analysts believe the stock has potential for growth. This positive sentiment among analysts could contribute to upward pressure on the stock price. 4. **Technical Indicators**: APLT's 52-week high is $9.39, and the 52-week low is $1.79. The stock's recent trading activity indicates a strong buying momentum, which could continue on September 20, 2024. 5. **Institutional Activity**: There has been an increase in institutional holdings of APLT, indicating confidence from large investors. This positive sentiment among institutional investors could contribute to upward pressure on the stock price. Considering these factors, it is reasonable to conclude that APLT is likely to go up on September 20, 2024. However, it is important to note that stock prices are subject to market fluctuations and uncertainties, and predictions should be used as a guide rather than a guarantee.